{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:39:48Z","timestamp":1773099588185,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":841,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jtct.2020.11.014","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T14:04:21Z","timestamp":1609423461000},"page":"187.e1-187.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cytomegalovirus-Specific Immunity Recovers More Slowly after Cord Blood Transplantation Compared with Matched Sibling Donor Allogeneic Transplantation"],"prefix":"10.1016","volume":"27","author":[{"given":"Nelli","family":"Bejanyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Vlasova-St Louis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham","family":"Mohei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najla","family":"El Jurdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio G.","family":"Brunstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2020.11.014_bib0001","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/bloodadvances.2017014464","article-title":"Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD","volume":"2","author":"Bejanyan","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2020.11.014_bib0002","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.bbmt.2015.02.017","article-title":"General and virus-specific immune cell reconstitution after double cord blood transplantation","volume":"21","author":"Saliba","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.014_bib0003","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbmt.2011.08.018","article-title":"Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation","volume":"18","author":"Jacobson","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.014_bib0004","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1182\/blood-2013-05-499830","article-title":"CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT","volume":"122","author":"Schmidt-Hieber","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.014_bib0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/14653240701231014","article-title":"Immune reconstitution after unrelated cord blood transplantation","volume":"9","author":"Szabolcs","year":"2007","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jtct.2020.11.014_bib0006","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bbmt.2015.01.023","article-title":"Higher dose of mycophenolate mofetil reduces acute graft-versus-host disease in reduced-intensity conditioning double umbilical cord blood transplantation","volume":"21","author":"Bejanyan","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.014_bib0007","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.bbmt.2016.08.005","article-title":"Sirolimus and mycophenolate mofetil as calcineurin inhibitor-free graft-versus-host disease prophylaxis for reduced-intensity conditioning umbilical cord blood transplantation","volume":"22","author":"Bejanyan","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.014_bib0008","first-page":"119","article-title":"Immune reconstitution disorders: spotlight on interferons","volume":"2","author":"Mohei","year":"2019","journal-title":"Int J Biomed Investig"},{"key":"10.1016\/j.jtct.2020.11.014_bib0009","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1172\/JCI22797","article-title":"T cell-dependent production of IFN-\u03b3 by NK cells in response to influenza A virus","volume":"114","author":"He","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2020.11.014_bib0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00281-018-0686-9","article-title":"Memory responses of innate lymphocytes and parallels with T cells","volume":"40","author":"Rapp","year":"2018","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jtct.2020.11.014_bib0011","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41409-019-0730-y","article-title":"Letermovir prophylaxis through day 100 post-transplant is safe and effective compared with alternative CMV prophylaxis strategies following adult cord blood and haploidentical cord blood transplantation","volume":"55","author":"Sharma","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.014_bib0012","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.bbmt.2020.07.002","article-title":"Letermovir prophylaxis decreases burden of cytomegalovirus (CMV) in patients at high risk for CMV disease following hematopoietic cell transplant","volume":"26","author":"Johnsrud","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.014_bib0013","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2020.11.014_bib0014","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3109\/14653249.2010.517518","article-title":"Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood","volume":"12","author":"Hanley","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jtct.2020.11.014_bib0015","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood-2012-08-448977","article-title":"Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation","volume":"121","author":"Blyth","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.014_bib0016","doi-asserted-by":"crossref","first-page":"306","DOI":"10.7326\/M19-2511","article-title":"Poxvirus vectored cytomegalovirus vaccine to prevent cytomegalovirus viremia in transplant recipients: a phase 2, randomized clinical trial","volume":"172","author":"Aldoss","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtct.2020.11.014_bib0017","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1182\/blood-2009-03-213256","article-title":"Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes","volume":"114","author":"Hanley","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.014_bib0018","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.014_bib0019","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41375-019-0600-z","article-title":"Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation\u2014a phase I\/II study","volume":"34","author":"Roex","year":"2020","journal-title":"Leukemia"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636720300403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636720300403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:00:53Z","timestamp":1763002853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636720300403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2666636720300403"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2020.11.014","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytomegalovirus-Specific Immunity Recovers More Slowly after Cord Blood Transplantation Compared with Matched Sibling Donor Allogeneic Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2020.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}